Skip to content

Clinical trials

Recruiting Leukemia, Myeloid, Acute trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Status: Recruiting Country / region: Czechia Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20201
20221
20231
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institute of Hematology and Blood Transfusion, Czech Republic1
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS1
Janssen Research & Development, LLC1
JaxBio Ltd1
Kura Oncology, Inc.1
Moleculin Biotech, Inc.1
PedAL BCU, LLC1
Taiho Oncology, Inc.1
University Hospital Pilsen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute9
Myelodysplastic Syndromes3
Anemia, Refractory, with Excess of Blasts2
Hematologic Neoplasms2
Leukemia2
Recurrence2
Disease1
Hematologic Diseases1
Hodgkin Disease1
Leukemia, Myelomonocytic, Chronic1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.